N22608
yw31f02.s1 Morton Fetal Cochlea Homo sapiens cDNA clone IMAGE:253851 3', mRNA sequence.
578
mRNA
Homo sapiens
MC774718
JP 2018525446-A/22608: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
31
PRT
synthetic construct
HW187636
JP 2013102767-A/22560: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
MD754850
JP 2019507579-A/22608: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
LX120224
JP 2017506877-A/22606: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
OG658994
JP 2021500321-A/22608: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
FU797089
JP 2009528046-A/22606: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
PA393331
JP 2021533803-A/22414: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
DM759302
JP 2014079248-A/22608: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
MB763520
JP 2018535655-A/27417: ASGR INHIBITORS.
11
PRT
synthetic construct
PD710522
JP 2021530475-A/22604: De novo Design of Protein Switches.
55
PRT
synthetic construct
PA527092
JP 2022502046-A/9874: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DD549211
JP 2004508801-A/22608: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria
DD802878
JP 2008525033-A/22608: Group B Streptococcus.
71
PRT
Streptococcus agalactiae
MC164452
JP 2019500349-A/22608: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
MD268741
JP 2020517247-A/22608: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
HZ527389
JP 2016501039-A/22608: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DJ952969
JP 2010500568-A/39650: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE.
261
PRT
Homo sapiens
LF681829
JP 2016521556-A/22608: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
HV879149
JP 2010507387-A/22560: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
HW857832
JP 2015051004-A/22560: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DL031622
JP 2005512499-A/22608: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
846
DNA
synthetic construct
DJ526408
JP 2010517930-A/22608: Method of constructing and screening libraries of peptide structures.
24
PRT
synthetic construct
MC906346
JP 2018536623-A/22608: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
40
PRT
synthetic construct
LF829764
JP 2016528161-A/22597: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
LV568430
JP 2017029159-A/22608: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DJ151988
JP 2007228956-A/22606: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
MC551108
JP 2019525738-A/22608: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
10
PRT
synthetic construct
MB811866
JP 2019502674-A/22608: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
42
PRT
synthetic construct
DM797066
JP 2014068652-A/22608: NEISSERIAL ANTIGENIC PEPTIDES.
12
PRT
Neisseria